Skander T. Mulder
Delft, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course.
Journal: Journal of medical Internet research
Published: December 14, 2021
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology.
Journal: Diabetes, obesity & metabolism
Published: November 09, 2021
A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes.
Journal: Diabetes, obesity & metabolism
Published: November 19, 2019
Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 18, 2019
Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: March 18, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease.
Journal: Diabetologia
Published: November 08, 2018
An integrative systems biology approach for precision medicine in diabetic kidney disease.
Journal: Diabetes, obesity & metabolism
Published: May 29, 2018
Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: July 08, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026